ALPHARETTA, Ga., April 29, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2020 on Wednesday, May 6 at 9 a.m. ET. The company will issue a news …
Avanos (AVNS) gains from segmental contributions in Q4.
AVNS earnings call for the period ending March 31, 2020.
This week we saw the Avanos Medical, Inc. (NYSE:AVNS) share price climb by 22%. But if you look at the last five years...
Q1 2020 Avanos Medical Inc Earnings Call
Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2020 financial results and provided an update on the actions it's taking in response to the COVID-19 pandemic.
Q4 2019 Avanos Medical Inc Earnings Call
Investors in Avanos Medical, Inc. (NYSE:AVNS) had a good week, as its shares rose 6.6% to close at US$32.84 following...
AVNS earnings call for the period ending March 31, 2020.
Avanos Medical (AVNS) delivered earnings and revenue surprises of -5.88% and 4.04%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
ALPHARETTA, Ga., May 6, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2020 financial results and provided an update on the actions it's taking in response to the COVID-19 pandemic. "I'm proud of the dedication our employe…
ALPHARETTA, Ga., April 29, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2020 on Wednesday, May 6 at 9 a.m. ET. The company will issue a news …
Avanos Medical, Inc. (NYSE: AVNS) announced today that, due to the increasing public health risk posed by COVID-19 and in accordance with current governmental state of emergency orders, its 2020 Annual Meeting of Stockholders will be changed from an in-person meeting to a virtual meeting to be held solely by means of remote communication.
Shares of Avanos Medical (NYSE:AVNS) were unchanged in pre-market trading after the company reported Q1 results.Quarterly Results Earnings per share rose 6.67% over the past year to $0.16, which were in line with the estimate of $0.16.Revenue of $180,400,000 rose by 9.87% year over year, which beat the estimate of $175,220,000.Outlook Avanos Medical hasn't issued any earnings guidance for the time being.Avanos Medical hasn't issued any revenue guidance for the time being.Conference Call Details Date: May 06, 2020View more earnings on AVNSWebcast URL: https://www.webcaster4.com/Webcast/Page/939/34129Technicals Company's 52-week high was at $48.0752-week low: $19.46Price action over last quarter: down 8.19%Company Profile Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. The firm operates in one segment, medical devices, which primarily sells products related to pain management, IV Therapy, and respiratory and digestive health. The company divides its Medical Devices segment into two franchises: Pain Management and Chronic Care. Pain Management provides non-opioid products for acute and interventional pain, including cold and compression therapy. Chronic Care aims at addressing digestive and respiratory issues with feeding tubes and catheters. Avanos generates most of its revenue from its Chronic Care franchise and in North America.See more from Benzinga * IEC Electronics: Q2 Earnings Insights * Recap: RPC Q1 Earnings * Recap: Sinclair Broadcast Group Q1 Earnings(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Avanos Medical's (AVNS) first-quarter results benefit from segmental contribution.
They have fallen behind in recent years compared to the S&P; 500 index Continue reading...
Avanos Medical (AVNS) delivered earnings and revenue surprises of 6.25% and 6.73%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
NEW YORK, March 18, 2020 -- Fields Kupka & Shukurov LLP is investigating potential breach of fiduciary duty claims involving the board of directors of Avanos Medical, Inc..
Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2020 financial results and provided an update on the actions it's taking in response to the COVID-19 pandemic.
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
Avanos Medical (AVNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Avanos Medical (AVNS) continues to benefit from strong performing segments and robust product portfolio. However, weak performance at Acute Pain unit raises concern.
Avanos Medical (AVNS) continues to benefit from strong performing segments and robust product portfolio. However, stiff competition remains a concern.
Avanos Medical (AVNS) continues to benefit from strong performing segments and robust product portfolio. However, stiff competition remains a concern.
Handout The denouement of Drive sees Angela White fixed to a cross, her Rubenesque body suspended high above a sea of sweaty, writhing figures. It is an arresting image—one of many comprising this porn epic that, at 3 hours and 29 minutes, clocks in one minu…
Avanos (AVNS) gains from solid fourth-quarter show despite headwinds in the Acute Pain business.